Cartalax
SKU：cartalax
Price：USD 70.00
Product information
Cartalax is a tripeptide composed of alanine, glutamic acid and aspartic acid. It belongs to short-peptide bioregulator research involving cartilage and connective-tissue models. Direct interactions of short peptides with DNA are a proposed research mechanism rather than an established receptor pathway. That hypothesis and the associated experimental findings do not establish clinical activity.
Product specifications
- Chemical Name
- Cartalax (Ala-Glu-Asp)
- Sequence
- L-Alanyl-L-Glutamyl-L-Aspartic acid (AED tripeptide)
- Molecular Weight
- 333.29 g/mol
- Molecular Formula
- C₁₂H₁₉N₃O₈
- Form
- Lyophilized powder
- Purity
- ≥99% (HPLC verified)
- Testing
- Third-party HPLC, Mass Spec, Endotoxin
- Storage
- -20°C for long-term stability
- Solubility
- Water-soluble
- Label amount
- 10mg
Analysis report
Cartalax 10mg · 10mg · R8S654
Research information
Read the full Cartalax research monograph
Research overview
Cartalax is a tripeptide composed of alanine, glutamic acid and aspartic acid. It belongs to short-peptide bioregulator research involving cartilage and connective-tissue models. Direct interactions of short peptides with DNA are a proposed research mechanism rather than an established receptor pathway. That hypothesis and the associated experimental findings do not establish clinical activity.